Life Science

Global Metabolomics Biomarker Market Analysis By Type, Application, Regions and Companies Forecast 2016-2027

Report Format PDF, PPT, Excel
No. of Pages 113
The latest study on Metabolomics Biomarker Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Metabolomics Biomarker Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Metabolomics Biomarker and is a must have data for all the companies, investors, decision makers, top level executives and readers. The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027. The major vendors covered: Biocrates Life Sciences Biomark Diagnostics Chenomx Creative Proteomics Evotec Human Metabolome Technologies Merck Metabolomic Diagnostics Metabolon Ovid Therapeutics Metabolomics Biomarker Market Analysis By Type Segment: Gas chromatography High-performance liquid chromatography Ultra-performance liquid chromatography Nuclear magnetic resonance Mass spectrometry Surface-based mass analysis Bioinformatics Metabolomics Biomarker Market Analysis By Application Segment: Toxicological studies Drug testing Cancer Cardiovascular disorders Neurological disorders Inborn errors of metabolism Metabolomics Biomarker Market Analysis By Regions (Countries): The Metabolomics Biomarker Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions. Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions. Key Details of Regions and Countries of Metabolomics Biomarker Report: North America United States Canada Mexico Europe Germany France UK Italy Russia Asia-Pacific China Japan South Korea India Australia Indonesia Thailand Malaysia Philippines Vietnam Central & South America Brazil Middle East & Africa Turkey GCC Countries Egypt South Africa Key data provided: Market Size of Regions Market Share of Regions Compound Annual Growth Rate (CAGR) Historic Data From 2016-2020 Forecast Data From 2021-2027 Competitive Landscape of Metabolomics Biomarker Market: Metabolomics Biomarker market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market. Key Questions Answered in Competitive Landscape- List of Key Players Revenue By players Market share of players Product Offerings The study objectives are: To analyze and research the Metabolomics Biomarker Market status and future forecast. To present the key Metabolomics Biomarker Market analysis of companies and present revenue, market share, and recent development for key players. To split the breakdown data by regions, type, companies and applications To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks. To identify significant trends, drivers, influence factors in global and regions To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Metabolomics Biomarker Market Size Growth Rate by Type (2016-2027) 1.4.2 Gas chromatography 1.4.3 High-performance liquid chromatography 1.4.4 Ultra-performance liquid chromatography 1.4.5 Nuclear magnetic resonance 1.4.6 Mass spectrometry 1.4.7 Surface-based mass analysis 1.4.8 Bioinformatics 1.5 Market by Application 1.5.1 Global Metabolomics Biomarker Market Share by Application (2016-2027) 1.5.2 Toxicological studies 1.5.3 Drug testing 1.5.4 Cancer 1.5.5 Cardiovascular disorders 1.5.6 Neurological disorders 1.5.7 Inborn errors of metabolism 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Metabolomics Biomarker Market Size 2.2 Metabolomics Biomarker Growth Trends by Regions 2.2.1 Metabolomics Biomarker Market Size by Regions (2016-2027) 2.2.2 Metabolomics Biomarker Market Share by Regions (2016-2020) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Metabolomics Biomarker Market Size by Manufacturers 3.1.1 Global Metabolomics Biomarker Revenue by Manufacturers (2020) 3.1.2 Global Metabolomics Biomarker Revenue Market Share by Manufacturers (2020) 3.1.3 Global Metabolomics Biomarker Market Concentration Ratio (CR5 and HHI) 3.2 Metabolomics Biomarker Key Players Head office and Area Served 3.3 Key Players Metabolomics Biomarker Product/Solution/Service 3.4 Date of Enter into Metabolomics Biomarker Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Metabolomics Biomarker Market Size by Type (2016-2020) 4.2 Global Metabolomics Biomarker Market Size by Application (2016-2020) 5 United States 5.1 United States Metabolomics Biomarker Market Size (2016-2020) 5.2 Metabolomics Biomarker Key Players in United States 5.3 United States Metabolomics Biomarker Market Size by Type 5.4 United States Metabolomics Biomarker Market Size by Application 6 Europe 6.1 Europe Metabolomics Biomarker Market Size (2016-2020) 6.2 Metabolomics Biomarker Key Players in Europe 6.3 Europe Metabolomics Biomarker Market Size by Type 6.4 Europe Metabolomics Biomarker Market Size by Application 7 China 7.1 China Metabolomics Biomarker Market Size (2016-2020) 7.2 Metabolomics Biomarker Key Players in China 7.3 China Metabolomics Biomarker Market Size by Type 7.4 China Metabolomics Biomarker Market Size by Application 8 Japan 8.1 Japan Metabolomics Biomarker Market Size (2016-2020) 8.2 Metabolomics Biomarker Key Players in Japan 8.3 Japan Metabolomics Biomarker Market Size by Type 8.4 Japan Metabolomics Biomarker Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Metabolomics Biomarker Market Size (2016-2020) 9.2 Metabolomics Biomarker Key Players in Southeast Asia 9.3 Southeast Asia Metabolomics Biomarker Market Size by Type 9.4 Southeast Asia Metabolomics Biomarker Market Size by Application 10 India 10.1 India Metabolomics Biomarker Market Size (2016-2020) 10.2 Metabolomics Biomarker Key Players in India 10.3 India Metabolomics Biomarker Market Size by Type 10.4 India Metabolomics Biomarker Market Size by Application 11 Central & South America 11.1 Central & South America Metabolomics Biomarker Market Size (2016-2020) 11.2 Metabolomics Biomarker Key Players in Central & South America 11.3 Central & South America Metabolomics Biomarker Market Size by Type 11.4 Central & South America Metabolomics Biomarker Market Size by Application 12 International Players Profiles 12.1 Biocrates Life Sciences 12.1.1 Biocrates Life Sciences Company Details 12.1.2 Company Description and Business Overview 12.1.3 Metabolomics Biomarker Introduction 12.1.4 Biocrates Life Sciences Revenue in Metabolomics Biomarker Business (2020) 12.1.5 Biocrates Life Sciences Recent Development 12.2 Biomark Diagnostics 12.2.1 Biomark Diagnostics Company Details 12.2.2 Company Description and Business Overview 12.2.3 Metabolomics Biomarker Introduction 12.2.4 Biomark Diagnostics Revenue in Metabolomics Biomarker Business (2020) 12.2.5 Biomark Diagnostics Recent Development 12.3 Chenomx 12.3.1 Chenomx Company Details 12.3.2 Company Description and Business Overview 12.3.3 Metabolomics Biomarker Introduction 12.3.4 Chenomx Revenue in Metabolomics Biomarker Business (2020) 12.3.5 Chenomx Recent Development 12.4 Creative Proteomics 12.4.1 Creative Proteomics Company Details 12.4.2 Company Description and Business Overview 12.4.3 Metabolomics Biomarker Introduction 12.4.4 Creative Proteomics Revenue in Metabolomics Biomarker Business (2020) 12.4.5 Creative Proteomics Recent Development 12.5 Evotec 12.5.1 Evotec Company Details 12.5.2 Company Description and Business Overview 12.5.3 Metabolomics Biomarker Introduction 12.5.4 Evotec Revenue in Metabolomics Biomarker Business (2020) 12.5.5 Evotec Recent Development 12.6 Human Metabolome Technologies 12.6.1 Human Metabolome Technologies Company Details 12.6.2 Company Description and Business Overview 12.6.3 Metabolomics Biomarker Introduction 12.6.4 Human Metabolome Technologies Revenue in Metabolomics Biomarker Business (2020) 12.6.5 Human Metabolome Technologies Recent Development 12.7 Merck 12.7.1 Merck Company Details 12.7.2 Company Description and Business Overview 12.7.3 Metabolomics Biomarker Introduction 12.7.4 Merck Revenue in Metabolomics Biomarker Business (2020) 12.7.5 Merck Recent Development 12.8 Metabolomic Diagnostics 12.8.1 Metabolomic Diagnostics Company Details 12.8.2 Company Description and Business Overview 12.8.3 Metabolomics Biomarker Introduction 12.8.4 Metabolomic Diagnostics Revenue in Metabolomics Biomarker Business (2020) 12.8.5 Metabolomic Diagnostics Recent Development 12.9 Metabolon 12.9.1 Metabolon Company Details 12.9.2 Company Description and Business Overview 12.9.3 Metabolomics Biomarker Introduction 12.9.4 Metabolon Revenue in Metabolomics Biomarker Business (2020) 12.9.5 Metabolon Recent Development 12.10 Ovid Therapeutics 12.10.1 Ovid Therapeutics Company Details 12.10.2 Company Description and Business Overview 12.10.3 Metabolomics Biomarker Introduction 12.10.4 Ovid Therapeutics Revenue in Metabolomics Biomarker Business (2020) 12.10.5 Ovid Therapeutics Recent Development 13 Market Forecast 2021-2027 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2021-2027) 13.10 Market Size Forecast by Application (2021-2027) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures

List of Tables and Figures Table Metabolomics Biomarker Key Market Segments Table Key Players Metabolomics Biomarker Covered Table Global Metabolomics Biomarker Market Size Growth Rate by Type 2016-2027 (Million US$) Figure Global Metabolomics Biomarker Market Size Market Share by Type 2016-2027 Figure Gas chromatography Figures Table Key Players of Gas chromatography Figure High-performance liquid chromatography Figures Table Key Players of High-performance liquid chromatography Figure Ultra-performance liquid chromatography Figures Table Key Players of Ultra-performance liquid chromatography Figure Nuclear magnetic resonance Figures Table Key Players of Nuclear magnetic resonance Figure Mass spectrometry Figures Table Key Players of Mass spectrometry Figure Surface-based mass analysis Figures Table Key Players of Surface-based mass analysis Figure Bioinformatics Figures Table Key Players of Bioinformatics Table Global Metabolomics Biomarker Market Size Growth by Application 2016-2027 (Million US$) Figure Toxicological studies Case Studies Figure Drug testing Case Studies Figure Cancer Case Studies Figure Cardiovascular disorders Case Studies Figure Neurological disorders Case Studies Figure Inborn errors of metabolism Case Studies Figure Metabolomics Biomarker Report Years Considered Table Global Metabolomics Biomarker Market Size 2016-2027 (Million US$) Figure Global Metabolomics Biomarker Market Size and Growth Rate 2016-2027 (Million US$) Table Global Metabolomics Biomarker Market Size by Regions 2016-2027 (Million US$) Table Global Metabolomics Biomarker Market Size by Regions 2016-2020 (Million US$) Table Global Metabolomics Biomarker Market Share by Regions 2016-2020 Figure Global Metabolomics Biomarker Market Share by Regions 2016-2020 Figure Global Metabolomics Biomarker Market Share by Regions 2020 Table Market Top Trends Table Global Metabolomics Biomarker Revenue by Manufacturers (2020) (Million US$) Table Global Metabolomics Biomarker Market Share by Manufacturers (2020) Figure Global Metabolomics Biomarker Market Share by Manufacturers in 2020 Table Global Metabolomics Biomarker Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Metabolomics Biomarker Product/Solution/Service Table Date of Enter into Metabolomics Biomarker Market Table Mergers & Acquisitions, Expansion Plans Table Global Metabolomics Biomarker Market Size by Type (2016-2020) (Million US$) Table Global Metabolomics Biomarker Market Size Share by Type (2016-2020) Figure Global Metabolomics Biomarker Market Size Market Share by Type (2016-2020) Table Global Metabolomics Biomarker Market Size by Application (2016-2020) (Million US$) Table Global Metabolomics Biomarker Market Size Share by Application (2016-2020) Figure Global Metabolomics Biomarker Market Size Market Share by Application (2016-2020) Figure Global Metabolomics Biomarker Revenue Market Share by Application in 2020 Figure United States Metabolomics Biomarker Market Size 2016-2020 (Million US$) Table United States Key Players Metabolomics Biomarker Revenue (2020) (Million US$) Table United States Key Players Metabolomics Biomarker Market Share (2020) Table United States Metabolomics Biomarker Market Size by Type (2016-2020) (Million US$) Table United States Metabolomics Biomarker Market Share by Type (2016-2020) Table United States Metabolomics Biomarker Market Size by Application (2016-2020) (Million US$) Table United States Metabolomics Biomarker Market Share by Application (2016-2020) Figure Europe Metabolomics Biomarker Market Size 2016-2020 (Million US$) Table Europe Key Players Metabolomics Biomarker Revenue (2020) (Million US$) Table Europe Key Players Metabolomics Biomarker Market Share (2020) Table Europe Metabolomics Biomarker Market Size by Type (2016-2020) (Million US$) Table Europe Metabolomics Biomarker Market Share by Type (2016-2020) Table Europe Metabolomics Biomarker Market Size by Application (2016-2020) (Million US$) Table Europe Metabolomics Biomarker Market Share by Application (2016-2020) Figure China Metabolomics Biomarker Market Size 2016-2020 (Million US$) Table China Key Players Metabolomics Biomarker Revenue (2020) (Million US$) Table China Key Players Metabolomics Biomarker Market Share (2020) Table China Metabolomics Biomarker Market Size by Type (2016-2020) (Million US$) Table China Metabolomics Biomarker Market Share by Type (2016-2020) Table China Metabolomics Biomarker Market Size by Application (2016-2020) (Million US$) Table China Metabolomics Biomarker Market Share by Application (2016-2020) Figure Japan Metabolomics Biomarker Market Size 2016-2020 (Million US$) Table Japan Key Players Metabolomics Biomarker Revenue (2020) (Million US$) Table Japan Key Players Metabolomics Biomarker Market Share (2020) Table Japan Metabolomics Biomarker Market Size by Type (2016-2020) (Million US$) Table Japan Metabolomics Biomarker Market Share by Type (2016-2020) Table Japan Metabolomics Biomarker Market Size by Application (2016-2020) (Million US$) Table Japan Metabolomics Biomarker Market Share by Application (2016-2020) Figure Southeast Asia Metabolomics Biomarker Market Size 2016-2020 (Million US$) Table Southeast Asia Key Players Metabolomics Biomarker Revenue (2020) (Million US$) Table Southeast Asia Key Players Metabolomics Biomarker Market Share (2020) Table Southeast Asia Metabolomics Biomarker Market Size by Type (2016-2020) (Million US$) Table Southeast Asia Metabolomics Biomarker Market Share by Type (2016-2020) Table Southeast Asia Metabolomics Biomarker Market Size by Application (2016-2020) (Million US$) Table Southeast Asia Metabolomics Biomarker Market Share by Application (2016-2020) Figure India Metabolomics Biomarker Market Size 2016-2020 (Million US$) Table India Key Players Metabolomics Biomarker Revenue (2020) (Million US$) Table India Key Players Metabolomics Biomarker Market Share (2020) Table India Metabolomics Biomarker Market Size by Type (2016-2020) (Million US$) Table India Metabolomics Biomarker Market Share by Type (2016-2020) Table India Metabolomics Biomarker Market Size by Application (2016-2020) (Million US$) Table India Metabolomics Biomarker Market Share by Application (2016-2020) Figure Central & South America Metabolomics Biomarker Market Size 2016-2020 (Million US$) Table Central & South America Key Players Metabolomics Biomarker Revenue (2020) (Million US$) Table Central & South America Key Players Metabolomics Biomarker Market Share (2020) Table Central & South America Metabolomics Biomarker Market Size by Type (2016-2020) (Million US$) Table Central & South America Metabolomics Biomarker Market Share by Type (2016-2020) Table Central & South America Metabolomics Biomarker Market Size by Application (2016-2020) (Million US$) Table Central & South America Metabolomics Biomarker Market Share by Application (2016-2020) Table Biocrates Life Sciences Company Details Table Biocrates Life Sciences Revenue in Metabolomics Biomarker Business (2020) (Million US$) Figure Biocrates Life Sciences Revenue Growth Rate in Metabolomics Biomarker Business (2020) Table Biocrates Life Sciences Recent Development Table Biomark Diagnostics Company Details Table Biomark Diagnostics Revenue in Metabolomics Biomarker Business (2020)(Million US$) Figure Biomark Diagnostics Revenue Growth Rate in Metabolomics Biomarker Business (2020) Table Biomark Diagnostics Recent Development Table Chenomx Company Details Table Chenomx Revenue in Metabolomics Biomarker Business (2020)(Million US$) Figure Chenomx Revenue Growth Rate in Metabolomics Biomarker Business (2020) Table Chenomx Recent Development Table Creative Proteomics Company Details Table Creative Proteomics Revenue in Metabolomics Biomarker Business (2020)(Million US$) Figure Creative Proteomics Revenue Growth Rate in Metabolomics Biomarker Business (2020) Table Creative Proteomics Recent Development Table Evotec Company Details Table Evotec Revenue in Metabolomics Biomarker Business (2020)(Million US$) Figure Evotec Revenue Growth Rate in Metabolomics Biomarker Business (2020) Table Evotec Recent Development Table Human Metabolome Technologies Company Details Table Human Metabolome Technologies Revenue in Metabolomics Biomarker Business (2020)(Million US$) Figure Human Metabolome Technologies Revenue Growth Rate in Metabolomics Biomarker Business (2020) Table Human Metabolome Technologies Recent Development Table Merck Company Details Table Merck Revenue in Metabolomics Biomarker Business (2020)(Million US$) Figure Merck Revenue Growth Rate in Metabolomics Biomarker Business (2020) Table Merck Recent Development Table Metabolomic Diagnostics Company Details Table Metabolomic Diagnostics Revenue in Metabolomics Biomarker Business (2020)(Million US$) Figure Metabolomic Diagnostics Revenue Growth Rate in Metabolomics Biomarker Business (2020) Table Metabolomic Diagnostics Recent Development Table Metabolon Company Details Table Metabolon Revenue in Metabolomics Biomarker Business (2020)(Million US$) Figure Metabolon Revenue Growth Rate in Metabolomics Biomarker Business (2020) Table Metabolon Recent Development Table Ovid Therapeutics Company Details Table Ovid Therapeutics Revenue in Metabolomics Biomarker Business (2020)(Million US$) Figure Ovid Therapeutics Revenue Growth Rate in Metabolomics Biomarker Business (2020) Table Ovid Therapeutics Recent Development Table Global Metabolomics Biomarker Market Size by Regions (Million US$) 2021-2027 Figure Global Metabolomics Biomarker Market Size Share by Regions (2021-2027) Figure Global Metabolomics Biomarker Market Size Share by Regions in 2027 Figure United States Metabolomics Biomarker Market Size Forecast (2021-2027)(Million USD) Figure Europe Metabolomics Biomarker Market Size Forecast (2021-2027)(Million USD) Figure China Metabolomics Biomarker Market Size Forecast (2021-2027)(Million USD) Figure Japan Metabolomics Biomarker Market Size Forecast (2021-2027)(Million USD) Figure Southeast Asia Metabolomics Biomarker Market Size Forecast (2021-2027)(Million USD) Figure India Metabolomics Biomarker Market Size Forecast (2021-2027)(Million USD) Figure Central & South America Metabolomics Biomarker Market Size Forecast (2021-2027)(Million USD) Table Global Metabolomics Biomarker Market Size by Product (2021-2027) (Million US$) Figure Global Metabolomics Biomarker Market Size by Product (2021-2027) Figure Global Metabolomics Biomarker Market Size by Product in 2027 Table Global Metabolomics Biomarker Market Size by Application (2021-2027) (Million US$) Figure Global Metabolomics Biomarker Market Size by Application (2021-2027) Figure Global Metabolomics Biomarker Market Size by Application in 2027 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Have questions about this research?

Speak directly with our analysts for custom insights

Contact Analyst
Starting From
$3900
$3900
$7800

Purchase Includes

PDF Report Comprehensive market analysis
PPT Presentation Executive summary slides
Excel Data Pack Market data & statistics
Analyst Support 10 hours of expert guidance
Free Updates 12 months data updates
Customization Up to 40 hours included

Have Any Questions?

Need a sample copy or have questions about pricing? Our team is here to help.

+1 646 583 1932